Free NHA CPT Practice Test

In loco parentis translates to “in the place of a parent.” Under legal and healthcare standards recognized by NHA, this status allows an authorized adult (such as a designated legal guardian, foster caregiver, or school authority) to grant consent for a minor's medical procedures, including venipuncture, when the biological parents are unavailable. An emancipated minor is an individual under 18 who has been granted adult legal status through marriage, military enlistment, or court decree, allowing them to consent to their own procedures rather than granting consent as a surrogate for another minor. The mature minor doctrine allows an adolescent who demonstrates sufficient maturity and understanding to independently consent to select medical treatments without parental notification; it does not refer to a surrogate adult granting consent. Respondeat superior (“let the master answer”) is a legal doctrine addressing vicarious liability where an employer is responsible for an employee's actions within their scope of practice, which is unrelated to patient consent.

According to NHA and clinical laboratory standards, specimen collection priorities are ranked by medical urgency: STAT tests must be drawn immediately due to life-threatening urgency, followed by Timed tests (which have strict physiological or medication-related windows), then ASAP tests (collected quickly but without a rigid schedule), and finally Routine tests. Listing Timed, STAT, ASAP, Routine incorrectly places Timed before STAT. STAT orders indicate immediate, potentially life-threatening clinical situations and always take the highest priority over all other orders. Listing ASAP, STAT, Timed, Routine mistakenly treats the phrase 'as soon as possible' as the highest clinical emergency, when STAT is the universally recognized top priority in the laboratory. Listing STAT, ASAP, Timed, Routine incorrectly prioritizes ASAP over Timed. While ASAP indicates a specimen should be drawn quickly, Timed tests (such as peak and trough drug levels or glucose tolerance tests) are bound to strict clock intervals and take precedence over ASAP orders.

Collecting the specimen 15 to 30 minutes before the next dose ensures the blood is drawn when the drug concentration is at its lowest point in the body. According to CLSI and NHA guidelines for therapeutic drug monitoring, trough levels must be drawn immediately prior to the next scheduled administration to ensure the medication clears safely without causing toxicity. Drawing blood halfway between doses confuses trough monitoring with general steady-state timing; therapeutic monitoring specifically requires the lowest (trough) or highest (peak) concentration, not a midpoint. Drawing 30 minutes after completing an IV dose targets the peak level—the highest concentration of the drug—rather than the trough level. Drawing 1 to 2 hours after oral administration represents the typical peak window for oral medications to allow for gastrointestinal absorption, not the trough window.

Resuscitation efforts must NOT be withheld based only on verbal claims from family members or visitors at the bedside. Per standard healthcare and BLS protocols, life-saving measures such as CPR must be initiated and maintained unless an official, legally valid physician order or institutional DNR band is confirmed. Checking for an official DNR (Do Not Resuscitate) band or alert is an appropriate and necessary action to confirm the patient's legal resuscitation preferences before or during emergency response. Candidates may mistakenly believe checking a band wastes valuable time. Positioning the patient supine on a firm, flat surface is a standard requirement to ensure chest compressions are effective. Candidates might confuse standard CPR positioning with recovery positioning used for breathing, conscious patients. Activating the code team or calling for help immediately is a required, life-saving initial action when discovering a pulseless patient. Candidates sometimes confuse calling for help with delaying care, but emergency activation ensures advanced life support arrives quickly.

This is correct because OSHA Bloodborne Pathogens Standard directives prohibit the manual removal or unscrewing of needles from tube holders after venipuncture. The entire needle and tube holder must be disposed of together as a single unit immediately into a rigid biohazard sharps container to prevent accidental needlesticks and splatter. This loses because utilizing the lid notch (unwinder) to detach needles from tube holders is prohibited by OSHA; tube holders are single-use disposable devices and must never be reprocessed or reused. This loses because used needles must never be discarded into flexible red biohazard bags, which can be easily punctured, and routine recapping before disposal is prohibited when an engineered safety device is present. This loses because unscrewing or manually detaching a contaminated needle from the holder significantly increases the risk of an accidental needlestick injury and is strictly prohibited by OSHA.

CLSI guidelines require sodium citrate tubes to maintain a strict 9:1 blood-to-anticoagulant ratio, which permits a 10% margin of error and requires a minimum 90% fill volume for accurate coagulation results. An 80% fill volume may be acceptable for non-critical additive tubes (such as heparin or EDTA in certain testing contexts), but it fails CLSI coagulation standards and leads to specimen rejection. Filling a sodium citrate tube to only 75% leaves an excess of liquid anticoagulant relative to blood, which binds too much calcium and causes falsely prolonged clotting times (such as PT/INR and aPTT). While filling directly to the manufacturer fill line is ideal, requiring exactly 100% is a common misconception; CLSI standards permit a ±10% tolerance range (meaning at least 90% full is clinically acceptable).

According to CLSI guidelines, holding the spreader slide at a 30° to 45° angle produces a blood smear covering one-half to two-thirds of the slide with a gradual transition to a distinct feathered edge containing a cellular monolayer. Holding the spreader slide at 10° to 15° creates a smear that is too thin and long, often running off the end of the glass. Candidates often confuse this with the shallow insertion angle used for butterfly needles in hand veins. Holding the spreader slide at 15° to 30° confuses slide preparation with the standard needle insertion angle for routine antecubital venipuncture. An angle below 30° produces an excessively long, thin blood film. Holding the spreader slide at 60° to 75° is too steep and results in a smear that is too thick and short, causing cells to clump together and preventing proper microscopic evaluation.

Per AABB and NHA standards, blood donor qualification follows a strict sequential protocol: donor registration and consent, followed by the health history interview, then the physical examination (vitals, weight, and hemoglobin or hematocrit testing), and finally the blood collection. This sequence incorrectly places the physical examination before donor registration. A donor must first be registered and identified before any clinical evaluations or vital sign measurements begin. This sequence incorrectly collects blood before conducting the physical examination and places donor registration at the very end rather than at the start. This sequence incorrectly places blood collection before screening. Donors must be fully evaluated and cleared through history and physical screening before any blood can be collected.

Hematocrit must be at least 38% (or hemoglobin ≥ 12.5 g/dL) for an allogeneic female donor (39% for males) per AABB and FDA donor eligibility standards. Although 36% falls within a standard clinical reference range for non-pregnant adult females, blood donation requires higher minimum levels to protect donor safety. Oral body temperature must not exceed 99.5°F (37.5°C). A temperature of 99.2°F (37.3°C) is acceptable; candidates often mistake any reading above the normal average of 98.6°F for a fever warranting deferral. Resting donor pulse must be between 50 and 100 beats/min (or lower in conditioned athletes with medical director approval). A rate of 58/min is acceptable; candidates often mistakenly apply the standard resting baseline threshold of 60 beats/min. Blood pressure must fall between 90 to 180 mm Hg systolic and 50 to 100 mm Hg diastolic. A reading of 138/88 mm Hg meets donor criteria; candidates often confuse clinical hypertension benchmarks with donation screening limits.

Scanning the barcode or entering the requisition number retrieves the electronic record in the laboratory information system (LIS), allowing the technician to verify physical tube labels against the system order. Once verified, documenting receipt confirms accessioning, and aliquot or secondary labels can be safely generated. Attempting to verify specimen labels against the LIS before scanning the barcode is impossible because the electronic patient record has not yet been retrieved on the screen. Documenting receipt status cannot occur before retrieving the order via barcode scan and verifying the physical specimen against LIS order specifications. Generating aliquot labels before verifying specimen labels and acceptability risks applying incorrect labels to sub-samples if the primary container has an order discrepancy.

Per The Joint Commission National Patient Safety Goals and CLSI guidelines, any critical or panic lab values delivered verbally must be verified through an immediate verbal read-back by the receiver. The phlebotomist must document the date, time, recipient's name, and confirmation that the read-back took place. Critical values must be communicated immediately once testing is verified; waiting for secondary authorization or a signed release from the laboratory director causes harmful delays in clinical intervention. Critical values require direct verbal contact with the ordering healthcare provider who can make immediate treatment decisions; posting to a patient portal does not fulfill urgent notification requirements. While electronic or paper reporting follows standard laboratory workflow, an immediate verbal notification with read-back is the mandatory safety standard, not an immediate simultaneous fax transmission.

90°F to 100°F is correct because NHA, CLSI, and federal workplace drug testing standards require the urine specimen temperature to fall between 90°F and 100°F (32°C to 38°C) within 4 minutes of collection to verify the sample is fresh and unadulterated. 98°F to 102°F is incorrect because candidates frequently confuse human core body temperature with the allowable urine collection range. Freshly voided urine immediately loses some heat to the ambient air and container, which is why regulatory guidelines permit a broader window down to 90°F. 85°F to 95°F is incorrect because 85°F is too cool for freshly voided urine. A reading below 90°F suggests the donor may have brought in a substitute sample from an outside source or diluted the sample with cool tap water. 94°F to 104°F is incorrect because a reading above 100°F is physiologically implausible for unadulterated human urine and suggests artificial warming or tampering with hot water.

According to OSHA and CLSI standards, the safety device must be activated immediately upon withdrawal from the vein to prevent accidental needlestick injuries and bloodborne pathogen exposure. Disassembling a contaminated needle from the holder creates an unnecessary hazard; OSHA requires the entire intact assembly to be discarded directly into the sharps container. Manually recapping needles is strictly prohibited under OSHA regulations because two-handed recapping is a primary cause of accidental puncture injuries. Placing an uncovered needle on the phlebotomy tray leaves an exposed contaminated sharp, creating an immediate needlestick hazard for both the technician and patient.

According to CLSI standards, the correct order of draw is sodium citrate (light blue), serum tube (red), EDTA (lavender), and sodium fluoride/potassium oxalate (gray) to prevent additive cross-contamination. Placing the gray tube before the lavender tube is incorrect; potassium oxalate/sodium fluoride from the gray tube can damage cell morphology if carried over into an EDTA tube. Placing the lavender tube before the red tube is incorrect; EDTA carryover into a serum tube causes falsely elevated potassium and falsely decreased calcium levels. Placing the red tube before the light blue tube is incorrect; drawing a serum tube with clot activator prior to a sodium citrate tube can introduce substances that alter coagulation test results.

This sequence correctly follows Clinical and Laboratory Standards Institute (CLSI) guidelines. Additive tubes must be inverted immediately after collection to ensure proper mixing and prevent micro-clots. Next, the phlebotomist must ensure the specimens are labeled at the bedside in the patient's presence, followed by a final visual confirmation against the patient's wristband before leaving. Labeling tubes before inverting them delays the critical mixing of anticoagulants and additives with whole blood, which risks micro-clot formation and specimen rejection. Transporting unlabeled tubes to the laboratory violates the core bedside labeling mandate, which requires all specimens to be labeled in the direct presence of the patient before the phlebotomist leaves the bedside. Pre-labeling tubes before venipuncture is a dangerous practice that violates CLSI standards and significantly increases the risk of catastrophic specimen misidentification if the draw is unsuccessful or tubes are mixed up.

A 23-gauge winged infusion set with small-volume tubes is the recommended combination for older adults with delicate or small vessels. The smaller gauge provides better control in superficial veins, while the lower vacuum pressure in small-volume (partial-draw) tubes minimizes the risk of vein collapse per CLSI guidelines. A 25-gauge needle with standard-draw tubes is incorrect because needles smaller than 23 gauge significantly increase the risk of hemolysis from red blood cell shearing, and standard-draw tubes create too much vacuum pull for fragile veins. An 18-gauge needle has an exceptionally large bore designed for blood donor collections and therapeutic phlebotomy, making it unsafe and inappropriate for routine venipuncture on fragile geriatric veins. A 21-gauge straight needle with standard-draw tubes is the standard choice for healthy adult antecubital veins, but the strong vacuum of full-draw tubes and the larger needle gauge can easily collapse fragile geriatric vessels and lead to hematoma formation.

Semen specimens must be delivered to the laboratory within 1 hour of collection and kept near body temperature to preserve sperm motility and viability per CLSI and NHA guidelines. Twelve hours is excessive for semen analysis; sperm cells lose motility and lyse long before this timeframe. Twenty-four hours confuses the test with a 24-hour urine collection period; semen samples must be evaluated promptly within 1 hour of ejaculation. Four hours is too long; delayed delivery leads to significant deterioration in sperm motility and viability, rendering fertility testing invalid.

A reclining phlebotomy chair or supine exam table allows the patient to lie back, which prevents falls and injury if the patient loses consciousness during the draw, per CLSI and NHA safety standards. A standard upright chair does not safely support a patient who experiences sudden loss of consciousness, posing a significant fall risk. A swivel exam stool lacks adequate back and arm support and can tip or rotate, creating a severe fall hazard if the patient faints. A wheelchair with raised footrests does not fully recline the upper body or prevent the patient from slumping forward during a syncopal episode.

STAT (derived from the Latin word statim, meaning immediately) signifies the highest priority for specimen collection, transport, and laboratory processing under CLSI guidelines, ensuring critical test results are delivered without delay. PRN stands for 'pro re nata,' which translates to 'as needed.' It refers to conditional orders rather than an urgent processing timeline. ASAP stands for 'as soon as possible.' Although it indicates that a specimen should be handled quickly, it is secondary in priority to a STAT order. QNS stands for 'quantity not sufficient,' which is a specimen rejection reason indicating inadequate sample volume, not an order priority.

45 mL is correct because per federal workplace drug testing standards recognized by NHA and SAMHSA, a split-specimen urine collection requires a minimum total volume of 45 mL (30 mL for the primary container and 15 mL for the split container). 15 mL is incorrect because this is the minimum volume allocated to the secondary (Bottle B) aliquot only, rather than the total volume collected from the donor. 60 mL is incorrect because while collection containers may hold 60 mL or more for standard clinical urinalysis, 45 mL is the regulatory minimum threshold for split-specimen chain of custody. 30 mL is incorrect because this represents only the volume allocated to the primary container (Bottle A) used for initial screening and confirmation, not the total required volume.

Under HIPAA guidelines, the phlebotomist must first verify the recipient's fax number to prevent unauthorized disclosure, attach a cover sheet with a standard confidentiality disclaimer, and finally check the transmission confirmation report to ensure the document was successfully sent to the intended machine. Placing the transmission confirmation first is incorrect because confirmation occurs at the conclusion of the faxing process, not before preparing and sending the documents. Placing verification of the recipient's fax number last is incorrect because verifying the number after transmission cannot prevent an accidental disclosure of PHI. Checking the transmission confirmation before attaching the confidentiality cover sheet is incorrect because the confirmation report is generated only after the entire fax package has been sent.

According to CLSI and NHA guidelines, fragile or sclerotic geriatric veins require a smaller-bore needle, such as a 23-gauge winged infusion set, combined with small-volume (low-vacuum) tubes or a syringe to prevent vein collapse and minimize vessel trauma. A 21-gauge straight needle with standard-volume evacuated tubes is the standard configuration for healthy adult veins, but standard vacuum pressure can easily collapse fragile geriatric veins. An 18-gauge needle is excessively large for diagnostic venipuncture (typically reserved for blood donor collections) and would cause severe tissue trauma and hematoma formation in a geriatric patient. Although a 25-gauge winged infusion set is small, extremely narrow bores significantly increase the risk of hemolysis, and pairing it with standard-volume evacuated tubes generates excessive suction that collapses delicate vessels.

This option is correct per CLSI guidelines. Blood cultures are drawn first in the order of draw to maintain sterility. When using a winged infusion set, the aerobic bottle must be drawn before the anaerobic bottle so that the ambient air in the tubing is evacuated into the aerobic bottle rather than destroying the oxygen-free environment of the anaerobic bottle. This option is incorrect because drawing the anaerobic bottle first when using a butterfly needle draws the air inside the tubing directly into the anaerobic bottle, which can inhibit or kill anaerobic microorganisms. Anaerobic is only inoculated first when transferring blood from a syringe. This option is incorrect because collecting a routine evacuated tube before blood culture bottles violates CLSI sterile collection protocols and increases the risk of contamination from non-sterile tube stoppers. This option is incorrect because blood culture sets must be collected together before transitioning to routine venipuncture tubes. Interspersing routine tubes between culture bottles compromises sterile technique and specimen integrity.

Diaphoresis is the medical term for profuse, excessive sweating. Per NHA and CLSI standards, diaphoresis (cold, clammy sweat) is a classic prodromal sign of a vasovagal reaction/syncope, alerting the phlebotomist to abort the procedure and protect the patient from injury. Dyspnea refers to shortness of breath or labored breathing, which is an indicator of respiratory or cardiac compromise rather than isolated vasovagal perspiration. Pallor refers to abnormal paleness or loss of color in the skin. While pallor is also an early sign of impending syncope, it describes skin coloration rather than excessive sweating. Cyanosis refers to a bluish discoloration of the skin and mucous membranes resulting from inadequate blood oxygenation, not perspiration.

Per CLSI guidelines and standard phlebotomy practice, 70% isopropyl alcohol requires 30 to 60 seconds to air-dry. This contact time ensures full antiseptic action while preventing patient discomfort and sample hemolysis. Waiting 4 to 5 minutes is unnecessarily prolonged for routine venipuncture and unnecessarily delays collection. Allowing only 5 to 10 seconds is insufficient contact time for the alcohol to kill surface bacteria and evaporate, which can lead to specimen hemolysis and sharp stinging for the patient. Waiting 2 to 3 minutes is longer than required for routine alcohol prep and mistakenly applies extended drying protocols used for certain blood culture preps or surgical scrubs.

According to CLSI and NHA guidelines, collecting a blood alcohol specimen requires cleansing the site with a non-alcohol antiseptic, such as povidone-iodine or benzalkonium chloride, to avoid chemical contamination that could falsely elevate the result. The antiseptic must air dry naturally to achieve adequate antimicrobial action, followed by venipuncture and collection into a gray-top tube containing sodium fluoride to preserve alcohol stability. Wiping the antiseptic dry with gauze disrupts proper antiseptic contact time and introduces potential contamination. Additionally, collecting into a lavender-top tube reflects the mistake of using EDTA rather than the required sodium fluoride additive found in gray-top tubes. Cleansing with 70% isopropyl alcohol introduces the common misconception that routine skin prep applies to all venipunctures; however, using alcohol pads can contaminate the specimen and falsely elevate blood alcohol concentration results, invalidating legal and clinical testing. Cleansing with 70% isopropyl alcohol, wiping the site dry with gauze, and using a green-top tube combines three procedural errors: alcohol contamination, improper drying technique, and using a heparin tube instead of an antiglycolytic gray-top tube.

OSHA and CLSI safety standards require sharps disposal containers to be closed and replaced when they reach two-thirds to three-fourths full to prevent overfilling and reduce the risk of accidental needlestick injuries. Replacing a sharps container when it is one-half full is premature, resulting in unnecessary operational expense and waste of disposal supplies. Allowing a container to become completely full is a dangerous practice that forces staff to push sharps down, significantly elevating the risk of puncture injuries. Waiting until the container is nine-tenths full creates a high hazard zone where discarded needles can protrude past the safety drop door.

According to CLSI standards, allowing the antiseptic to air-dry completely ensures full antimicrobial action. Complete drying also prevents specimen hemolysis and minimizes the sharp stinging sensation caused when residual alcohol enters the puncture site. Fanning the site with a gloved hand or blowing on the skin is incorrect because moving air currents carry airborne microorganisms directly onto the prepped area, recontaminating the skin. Repalpating the vein after cleansing is incorrect because touching the puncture area recontaminates the site. If repalpation is necessary, the site must be cleansed again prior to needle insertion. Blotting the site dry with sterile gauze is incorrect because it wipes away the antiseptic before it can complete its antimicrobial action and introduces unnecessary contact that can compromise sterility.

Diagnosis codes (such as ICD-10-CM codes) document the patient's symptoms, condition, or clinical reason for the encounter, which demonstrates medical necessity for the ordered laboratory tests to insurance payers and regulatory bodies. Current Procedural Terminology (CPT) codes identify the specific procedure or service provided for billing purposes, but they do not describe the underlying patient condition or clinical justification. Test priority indicates the collection timing and turnaround urgency (e.g., STAT, timed, routine), rather than the clinical reason the test is required. An accession number is a unique alphanumeric tracking code assigned to a specimen by the laboratory information system (LIS) during order entry and processing, not a clinical justification.

Per CLSI guidelines, sodium citrate tubes require only 3 to 4 gentle inversions. Excessive agitation can cause premature platelet activation and artifactually alter coagulation test results, while under-mixing leads to microclot formation. K2EDTA tubes require 8 to 10 inversions to thoroughly bind calcium and prevent microclots from compromising complete blood counts. Lithium heparin tubes require 8 to 10 inversions to ensure the anticoagulant thoroughly inhibits thrombin throughout the sample. Sodium fluoride tubes require 8 to 10 inversions to fully distribute both the antiglycolytic agent and the anticoagulant.

According to CDC and OSHA airborne precaution guidelines, all PPE (gloves, gown, face protection) is removed inside the room before exiting, but the N95 respirator must be removed outside the room after closing the door. Because airborne droplet nuclei remain suspended in the air, doffing respiratory protection inside the room would expose the phlebotomist to infectious particles. Doffing the respirator while still inside the room exposes the phlebotomist's airway to lingering infectious aerosols before they exit. For airborne precautions, the mask or respirator must always be removed after exiting and closing the door. The gown is contaminated and must be removed inside the patient's room prior to exiting. Stepping into the hallway while still wearing a contaminated gown violates isolation protocol and risks spreading pathogens to clean facility areas. Gloves are the most contaminated piece of PPE and must always be removed first, inside the patient room. Carrying contaminated gloves into a clean hallway or anteroom risks cross-contamination of doorknobs and surfaces.

According to CLSI order of draw standards, blood cultures must always be drawn first to prevent microbial contamination from the stoppers of other tubes. Light blue (sodium citrate) follows for coagulation testing, and lavender (EDTA) is drawn later for hematology. Drawing lavender before light blue is incorrect because EDTA contains potassium and chelates calcium, which causes carryover interference that invalidates coagulation tests in the light blue tube. Drawing lavender first is incorrect because EDTA is drawn toward the end of the sequence to avoid additive carryover, and blood cultures must always be drawn first to maintain sterility. Drawing light blue before blood cultures violates CLSI sterile collection protocols because introducing another tube first increases the risk of bacterial contamination from non-sterile tube stoppers.

Per CLSI guidelines, a light blue sodium citrate tube requires a 9:1 blood-to-anticoagulant ratio (9 parts whole blood to 1 part 3.2% sodium citrate). Maintaining this exact proportion is critical; an underfilled tube has excess liquid citrate that binds the calcium added during testing, causing falsely prolonged coagulation results such as PT/INR and aPTT. The ratio 4:1 is the blood-to-additive ratio used in black-top tubes for Westergren erythrocyte sedimentation rate (ESR) determinations, not routine coagulation testing. The ratio 10:1 is an incorrect value resulting from confusing the 90% minimum tube fill level requirement with the blood-to-anticoagulant ratio. The ratio 1:9 reverses the components, representing anticoagulant to blood rather than blood to anticoagulant. Test takers often make this reversal error when reading ratio questions quickly.

According to CDC and OSHA guidelines, gloves are considered the most contaminated piece of PPE and must be removed first to avoid contaminating hands or clean parts of other PPE during removal. Goggles or face shields are removed after gloves have been safely discarded to ensure contaminated gloves do not touch the face or eyes. The gown is removed after gloves (or simultaneously in a combined technique), because touching the gown with soiled gloves can transfer pathogens to the ties and clothing. The mask or respirator is removed last (after leaving the patient area) so the phlebotomist remains protected against airborne or droplet particles throughout the entire doffing process.

Icterus is an in vivo physiological condition caused by elevated bilirubin levels in the patient's blood rather than a phlebotomy collection error. Because redrawing the patient will not alter the bilirubin level, CLSI standards direct laboratories to process the specimen and report or note the index rather than reject it. Hemolysis causes red blood cells to rupture and release intracellular potassium into the serum or plasma, causing falsely elevated results. This pre-analytical collection error is a critical reason for rejection. Light blue sodium citrate tubes require a precise 9:1 blood-to-anticoagulant ratio. Underfilling leaves excess unbound citrate, which binds reagent calcium and falsely prolongs coagulation times, requiring specimen rejection. Microclots in an EDTA tube trap platelets and white blood cells, falsely lowering automated cell counts and potentially clogging laboratory analyzers. CLSI guidelines require complete rejection and a redraw.

According to CLSI and NHA guidelines, the phlebotomist must first introduce themselves by stating their name, professional title, and department before proceeding with patient identification and consent. This establishes professional rapport and clarifies the phlebotomist's role. Providing expected turnaround times may be discussed later if the patient inquires, but it is not part of the required initial greeting. Describing complications prior to introducing oneself and establishing identity is out of order and can create unnecessary patient anxiety. Explaining the clinical or diagnostic reasons for laboratory tests falls outside the phlebotomy scope of practice and should be directed to the ordering provider.

Cold agglutinins are autoantibodies that react at lower temperatures. Per CLSI guidelines, collection tubes must be pre-warmed to and maintained at body temperature (37°C / 98.6°F) until the serum is separated to prevent the antibodies from attaching to erythrocytes. Standard refrigeration at 4°C causes cold agglutinin antibodies to bind to red cells before centrifugation, leading to falsely low titer results in the separated serum. Room temperature (approximately 22°C) is too cool for this analyte; agglutination begins as soon as the blood cools below normal body temperature. Transporting at 0°C (an ice slurry) is appropriate for analytes like ammonia and lactic acid, but cooling a cold agglutinin specimen triggers antibody binding to red blood cells and ruins the sample.

Medical asepsis (also known as clean technique) focuses on reducing the number and inhibiting the transmission of pathogenic microorganisms, and the CDC identifies routine hand hygiene as its primary component. Disinfection is the chemical or physical process of reducing or eliminating pathogens on inanimate objects and surfaces, not the practice of cleansing hands. Sterilization is the total destruction of all microbial life and spores on instruments using methods such as autoclaving, which cannot be performed on living tissue. Surgical asepsis (sterile technique) involves procedures that completely eliminate all microorganisms and bacterial spores before invasive surgical operations, which goes beyond standard hand hygiene.

According to CDC and OSHA airborne precaution guidelines, the N95 respirator must remain on until after exiting the room and closing the door to prevent inhaling suspended droplet nuclei. Gowns must be removed inside the patient room before crossing the threshold into the hallway to avoid transferring pathogens to clean clinical areas. Face shields and goggles protect the mucous membranes from splashes and are doffed inside the room prior to exit. Gloves are removed inside the patient room as the initial step in doffing because they harbor the highest concentration of surface contaminants.

A 23-gauge needle has a smaller diameter, making it the ideal choice for small, fragile, or delicate veins often found in geriatric patients to minimize trauma and reduce the risk of hematoma or vein collapse. A 21-gauge needle is considered the standard gauge for routine adult venipuncture on healthy antecubital veins, but it is typically too large for small or fragile geriatric veins. An 18-gauge needle is a large-bore needle used primarily for specialized procedures such as collecting units for therapeutic phlebotomy, and using it on fragile veins would cause severe tissue trauma. A 16-gauge needle is an extra-large bore needle reserved for blood donor collections to prevent hemolysis during rapid blood flow, and is far too large for diagnostic geriatric draws.

STAT orders carry the highest priority over all other laboratory requests because the results are needed immediately for critical, life-saving clinical decisions. Timed collections, such as therapeutic drug monitoring (peak and trough levels), require precise scheduling but are secondary to emergency STAT requests. ASAP orders indicate the provider needs results quickly, but the patient is stable and the draw can wait until STAT and critically timed specimens are collected. Routine fasting tests have the lowest urgency among these options and should be drawn after STAT, timed, and ASAP requisitions have been addressed.

Chain of custody protocols require a continuous, unbroken record of specimen possession. Whenever custody is transferred to another individual (such as a laboratory courier), the phlebotomist and the courier must sign and document the date and time of the handoff on the chain of custody form per NHA and CLSI guidelines. Centrifuging and opening legal blood tubes alters specimen integrity and violates standard chain of custody collection protocols; forensic blood samples are typically maintained and transported as whole blood under intact seals. Breaking the tamper-evident seal compromises specimen integrity and legally invalidates the chain of custody, rendering the specimen inadmissible for forensic testing. Placing the chain of custody form inside the primary specimen bag risks contamination from potential specimen leaks and prevents the document from being reviewed without compromising the specimen compartment; paperwork belongs in the external document pouch.

Under CLSI guidelines, the basal state represents the body's resting metabolic status early in the morning, approximately 12 hours after the last ingestion of food and following a period of overnight rest and minimal physical exertion. Resting in a seated position for 30 minutes after eating reflects a postprandial state, which significantly alters metabolic analytes like glucose and triglycerides and directly violates the fasting requirement of the basal state. Abstaining from all prescription medications for 24 hours is incorrect because patients should continue taking prescribed maintenance medications unless explicitly instructed to withhold them by the ordering physician for therapeutic drug monitoring. Fasting for 8 hours with complete fluid restriction describes an NPO-type restriction rather than basal state criteria; the basal state requires approximately 12 hours of fasting, and moderate water consumption is generally permitted to prevent dehydration and hemoconcentration.

Serum separator tubes (SST) contain a clot activator and are designed to yield serum; the blood MUST clot completely (typically 30 to 60 minutes) prior to centrifugation. Therefore, a clotted SST is expected and fully acceptable under CLSI guidelines. EDTA tubes contain an anticoagulant to maintain whole blood for hematology analysis; the presence of clots consumes platelets and alters cellular counts, making this an automatic reason for rejection. Proper specimen labeling with two unique patient identifiers is a fundamental CLSI and NHA safety requirement; unlabeled tubes can never be processed and must be rejected. Hemolysis causes red blood cells to rupture and release intracellular potassium into the plasma or serum, leading to falsely elevated results that require specimen rejection.

Obtaining a verbal read-back of the result ensures that critical data is received and transcribed correctly by the provider, fulfilling The Joint Commission and CLSI standards for immediate, closed-loop communication. Leaving a detailed voicemail is inappropriate because critical values represent potentially life-threatening findings requiring direct, real-time communication with authorized personnel; voicemail also creates an unauthorized disclosure risk under HIPAA. Requiring written authorization confuses general release-of-information consent with delivering diagnostic results to the ordering physician; delaying critical value reporting for administrative paperwork endangers the patient. Mailing an official printed report pertains to non-urgent medical records archiving and does not provide the immediate communication required for a critical value.

1 minute is the maximum allowable time established by CLSI guidelines because leaving the tourniquet on any longer leads to localized stasis and hemoconcentration, which artificially elevates values for proteins, cells, and potassium. 2 minutes is a common misconception, but it exceeds the CLSI standard and is long enough to alter laboratory test results via hemoconcentration. 4 minutes is far too long for tourniquet application and can lead to severe hemoconcentration, erroneous analyte readings, and hematoma formation. 3 minutes is well beyond the safe limit and significantly increases patient discomfort and the risk of specimen rejection.

CLSI guidelines require a 9:1 blood-to-anticoagulant ratio (9 parts whole blood to 1 part 3.2% sodium citrate) to ensure valid PT/INR and aPTT results. This reflects a common calculation error; while sodium citrate makes up 10% of the total liquid volume, the ratio of blood to anticoagulant is 9:1, not 10:1. This inverts the components; 1:9 is the anticoagulant-to-blood ratio rather than the blood-to-anticoagulant ratio. This is the blood-to-additive ratio used in black-top tubes for Westergren erythrocyte sedimentation rate (ESR) testing, not routine coagulation tubes.

Per CLSI and NHA standards, the basal state represents the body's resting metabolic state early in the morning after approximately 12 hours of fasting and physical rest. Fasting for 4 hr is inadequate to deplete circulating postprandial nutrients and does not allow the body to reach baseline equilibrium. Fasting for 8 hr is a common minimum required for basic fasting glucose tests, but it does not meet the full standard required for a true basal state. Fasting for 24 hr represents extended fasting or starvation, which skews laboratory values by elevating ketones, bilirubin, and uric acid rather than capturing a normal baseline.

According to OSHA and CDC post-exposure guidelines, phlebotomists should never forcefully squeeze, milk, or press on a needlestick wound. Squeezing causes localized tissue trauma and inflammation, which does not reduce the risk of pathogen transmission and may actually facilitate infection spread into deeper tissues. Reporting the incident immediately to a supervisor is a required standard step under an Exposure Control Plan to begin timely documentation and medical follow-up. Seeking prompt medical evaluation is a necessary step because post-exposure prophylaxis (PEP) is most effective when initiated as soon as possible after bloodborne pathogen exposure. Washing the puncture site immediately with soap and water is the primary initial step required by OSHA and CDC guidelines to reduce surface pathogen load.

A trough level measures the lowest concentration of a drug in the bloodstream and must be collected immediately prior to the next administration, typically within 15 to 30 minutes before the next scheduled dose per CLSI standards. Collecting a specimen 30 minutes after intravenous administration measures the peak level (the highest drug concentration), not the trough level. Collecting a specimen midway between doses measures an intermediate steady-state concentration and misses the lowest concentration point. Collecting a specimen 2 hours after administration reflects the peak absorption window for many oral medications rather than the lowest concentration.